Press releases

Access the RSS feed

21/07/2026 - 08:45

When Festivals Become the Beginning of a Journey: Discover Malaysia at Each Individual's Pace, with Meaningful Moments Throughout the Trip

Media OutReach...

21/07/2026 - 07:00

Ant International Raises approx. US$1.2 billion in Series A Equity Financing to Boost Cross-border Payments, Agentic Commerce Solutions for Global Businesses

Ant International, a leading global digital payment, digitisation and financial technology provider, today announced the successful closing of its Series A equity financing of approximately US$1.2 billion. Existing investors including Ant Group and Alibaba Group participated in this round...

21/07/2026 - 06:55

Philippine Airlines Selects GE Aerospace GEnx engines to Power New 787-10 Dreamliners

Media OutReach...

21/07/2026 - 06:15

ST Telemedia Global Data Centres Delivers on Responsible Scaling, Surpassing 2028 Carbon Intensity Target Three Years Early with Renewables at 83.2%

Media OutReach...

21/07/2026 - 06:00

SearchInform: A Risky Game – How FIFA World Cup 2026 Led to Mass Corporate Data Leaks

Media OutReach...

21/07/2026 - 06:00

TELOSIN Introduces "The Dual Transformation," Pairing Y PRO Red and Y PRO Blue with the New Lumiactive Collection

Media OutReach...

21/07/2026 - 05:00

Malaysian Companies Invited to Register for INSP MIHAS 2026

Media OutReach...

21/07/2026 - 04:00

Microsoft Platforms Drive AI Modernization in Asia Pacific

Enterprises across Asia Pacific are increasingly incorporating Microsoft cloud and AI platforms into integrated operating environments as they respond to economic uncertainty, evolving regulations and intensifying competition, according to a new research report published today by Information Services Group (ISG) (Nasdaq...

21/07/2026 - 00:30

Fermi Announces Second Quarter 2026 Earnings Release and Call Date

Fermi to host earnings call on August...

21/07/2026 - 00:00

Brenus Pharma Welcomes New European and Asia-Pacific Life Sciences Investors in Series A Extension

Brenus Pharma today announced an €11 million ($12.6M) extension to its Series A round, bringing total capital raised since inception to €38 million ($43.5M). This funding reflects strong execution across clinical, regulatory, and business development milestones, de-risking STC-1010(NCT06934538): lead clinical-stage in-vivo immunotherapy for MSS...